The Medicines Verification System will be used throughout the pharmaceutical supply chain by February 2019. In Finland, we aim for our national system to be fully operational in November 2018.
The introduction of the verification system requires changes to existing IT systems at least in pharmacies, pharmaceutical wholesalers, pharmaceutical companies and parallel traders. Pharmacies include both private pharmacies as well as public and private hospital pharmacies and dispensaries.
Pharmaceutical companies and parallel traders’ IT systems are directly connected with the central repository (EU Hub). The pharmaceutical industry submits their master data as well as the information in the unique identifier (unique serial number, product code, batch number and expiry date) for all serialized batches that will be brought to the market into the European Hub.
The EU Hub then distributes this information to all necessary National Medicines Verification Systems (NMVS).
Pharmacies and wholesalers compare the information on the medicine pack to the data in the national repository. The verification of the 2D-matrixes on medicines packs requires a scanner capable of reading the code. If the verification process result is positive, the medicine pack can be decommissioned from the system.
The basic principle is that the unique identifier should always be decommissioned from the system as close to the end user, the patient, as possible. Thus, the risk of potential falsified medicines gaining access to the legal supply chain, can be minimized.
The Finnish NMVS is supplied by Arvato Systems. Arvato is the chosen provider also in several other countries (e.g. Norway, Germany, France and Spain).
The ramp-up project
The construction of the Finnish NMVS is well underway. The technical project manager for the ramp-up of the system is Tero Vesa. You can reach him at firstname.lastname@example.org or +358 400 416698. If you have any questions related to any IT issues of the project, please be in touch with Tero.